Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation

https://doi.org/10.17749/2070-4909/farmakoekonomika.2021.082

Full Text:

Abstract

Objective: early assessming the clinical and economic efficacy of the thrombodynamics test in infertile patients undergoing treatment with assisted reproductive technologies (ART), as well as the impact of this test on the health care budget of the Russian Federation.

Material and methods. The study was carried out on the basis of statistical data on the number of ART cycles, the proportion of patients with hypercoagulation and normocoagulation of blood, data on the clinical effectiveness of ART programs in Russia, including the dependency on the status of blood coagulation, as well as cost data. The analysis was carried out according to three scenarios: 1) thrombodynamics test with subsequent correction of the revealed hypercoagulability status before in vitro fertilization (IVF); 2) thrombodynamics test with the subsequent refusal to perform IVF in patients with hypercoagulability; 3) thrombodynamics test with subsequent correction of the revealed hypercoagulability status before the start of the frozen-thawed embryo transfer. The criteria for clinical effectiveness were the following indicators: the number of children born and the number of potentially saved life years. Clinical and economic efficacy criteria included: total direct medical costs; incremental cost-effectiveness ratio (ICER); changes in the amount of total direct medical costs; resizing effectively and ineffectively spent funds.

Results. The use of the thrombodynamics test will potentially increase the number of children born by 21–33 children and the number of years of life saved, with discounting considered, within the range of 923–1448 years per 1000 ART cycles, depending on the study scenario. The smallest ICER values were observed in Scenario 2, and amounted to 112,120 rubles for 1 child born and 2519 rubles for 1 saved year of life. The highest ICER values were obtained in Scenario 1: 275,576 rubles for 1 child born and 6191 rubles for 1 saved year of life. The use of the thrombodynamics test in women with infertility before ART in Russia will require an increase in direct medical costs from 174 to 425 million rubles (by 1–5% of the initial level of costs) in absolute terms, depending on the chosen scenario with a time horizon of 1 year.

Conclusion. Due to the expected significant improvement in treatment outcomes and the small amount of additional costs, the introduction of the thrombodynamics test into the routine practice of assessing blood clotting in infertile patients before the start of the ART cycle is potentially cost-effective, but further clinical studies are required for a more accurate economic assessment.

About the Authors

D. G. Shchurov
Center for Expertise and Quality Control of Medical Care
Russian Federation

Dmitriy G. Shchurov – MD, PhD, Deputy Head of the Development and External Communications Department. RSCI SPIN-code: 8874-7585

10/5 Khokhlovskiy Pereulok, Moscow 109028, Russia



V. S. Dombrovskiy
Center for Expertise and Quality Control of Medical Care
Russian Federation

Vladislav S. Dombrovskiy – Chief Specialist of the Development and External Communications Department. RSCI SPIN-code: 3756-2613

10/5 Khokhlovskiy Pereulok, Moscow 109028, Russia



References

1. Filippov О.S. Causes and factors of infertility among the population of Siberia. Epidemiology and Infectious Diseases. 2002; 3: 47 (in Russ.).

2. Ustinova T.A., Artimuk N.V., Vlasova V.V., Pyshov A.Y. Infertility in couples of Kemerovo Region. Mother and Baby in Kuzbass. 2010; 1: 37–9 (in Russ.).

3. Frolova N.I., Belokrinitskaya T.E., Anokhova L.I., et al. Prevalence and characteristics of infertility in young women of reproductive age living in Zabaykalsky District. Bulletin of Eastern-Siberian Scientific Center. 2014; 4: 54–8 (in Russ.).

4. Darzhaev Z.Y., Atalyan A.V., Rinchindorzhiyeva M.P., Suturina L.V. Prevalence of female infertility among urban and rural population in Buryat Republic. Fundamental and Clinical Medicine. 2017; 2 (4): 14–21 (in Russ.).

5. Russian Association of Reproduction Register. Report for 2018. Available at: https://rahr.ru/d_registr_otchet/RegistrART2018.pdf (accessed 19.03.2021) (in Russ.).

6. Murashko A.V., Murashko A.A. Use of anticoagulation therapy in assisted-reproductive technologies. Doctor.Ru. 2015; 11: 12–6 (in Russ.).

7. Balandina A.N., Koltsova E.M., Teterina T.A., et al. An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy. PLoS ONE. 2019; 14 (5): e0216724. https://doi.org/10.1371/journal.pone.0216724.

8. Panteleev М.А., Vasil’ev S.А., Sinauridze Е.I., et al. Practical coagulology. Мoscow: Prakticheskaya meditsina; 2012 (in Russ.).

9. The program of state guarantees of free provision of medical care to citizens for 2021 and for the planning period of 2022 and 2023. Available at: https://www.garant.ru/products/ipo/prime/doc/400065890/ (accessed 19.03.2021) (in Russ.).

10. Federal State Statistics Service. Demographics. Available at: https://rosstat.gov.ru/folder/12781 (accessed 19.03.2021) (in Russ.).

11. Price list of Mother and Child clinics in Saint Petersburg. Available at: https://sankt-peterburg.mamadeti.ru/price-list/ (accessed 19.03.2021) (in Russ.).

12. Unified information system in the field of procurement. Available at: https://zakupki.gov.ru/epz/main/public/home.html (accessed 19.03.2021) (in Russ.).

13. Bertram M.Y., Lauer J.A., De Joncheere K., Edejer T., et al. Cost–effectiveness thresholds: pros and cons. Bull World Health Organ. 2016; 94 (12): 925–30. https://doi.org/10.2471/blt.15.164418.

14. Teptsova T.S., Musina N.Z., Omelyanovsky V.V. Evaluation of the reference value of the incremental parameter “cost–effectiveness” for Russian healthcare system. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020; 13 (4): 367–76 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.071.


For citation:


Shchurov D.G., Dombrovskiy V.S. Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2021;14(2):124–135. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2021.082

Views: 149


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)